ID   KCNK2_RAT               Reviewed;         426 AA.
AC   Q920B6; A3QR52; Q3MMY3; Q5DNW4; Q5DNW5;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-OCT-2024, entry version 139.
DE   RecName: Full=Potassium channel subfamily K member 2 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Outward rectifying potassium channel protein TREK-1 {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Stretch-activated potassium channel TREK-1 {ECO:0000303|PubMed:16248991};
DE   AltName: Full=TREK-1 K(+) channel subunit {ECO:0000250|UniProtKB:O95069};
DE   AltName: Full=Two pore domain potassium channel TREK-1 {ECO:0000303|PubMed:24196565};
DE   AltName: Full=Two pore potassium channel TPKC1 {ECO:0000250|UniProtKB:O95069};
GN   Name=Kcnk2 {ECO:0000312|EMBL:AAU06141.1, ECO:0000312|RGD:621448};
GN   Synonyms=Trek {ECO:0000312|EMBL:ABD64605.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL01159.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAL01159.1};
RX   PubMed=11319556; DOI=10.1038/87434;
RA   Bockenhauer D., Zilberberg N., Goldstein S.A.;
RT   "KCNK2: reversible conversion of a hippocampal potassium leak into a
RT   voltage-dependent channel.";
RL   Nat. Neurosci. 4:486-491(2001).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAL95708.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAL95708.1};
RX   PubMed=11897838; DOI=10.1113/jphysiol.2001.013432;
RA   Gu W., Schlichthorl G., Hirsch J.R., Engels H., Karschin C., Karschin A.,
RA   Derst C., Steinlein O.K., Daut J.;
RT   "Expression pattern and functional characteristics of two novel splice
RT   variants of the two-pore-domain potassium channel TREK-2.";
RL   J. Physiol. (Lond.) 539:657-668(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAU25945.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TRANSPORTER ACTIVITY,
RP   ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16248991; DOI=10.1016/j.cardiores.2005.08.018;
RA   Tao Li X., Dyachenko V., Zuzarte M., Putzke C., Preisig-Muller R.,
RA   Isenberg G., Daut J.;
RT   "The stretch-activated potassium channel TREK-1 in rat cardiac ventricular
RT   muscle.";
RL   Cardiovasc. Res. 69:86-97(2006).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:ABD64605.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5), FUNCTION, TRANSPORTER
RP   ACTIVITY, SUBCELLULAR LOCATION (ISOFORMS 1; 2 AND 5), TISSUE SPECIFICITY,
RP   AND DOMAIN (ISOFORM 5).
RX   PubMed=24196565; DOI=10.1007/s00424-013-1384-z;
RA   Rinne S., Renigunta V., Schlichthorl G., Zuzarte M., Bittner S.,
RA   Meuth S.G., Decher N., Daut J., Preisig-Muller R.;
RT   "A splice variant of the two-pore domain potassium channel TREK-1 with only
RT   one pore domain reduces the surface expression of full-length TREK-1
RT   channels.";
RL   Pflugers Arch. 466:1559-1570(2014).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar {ECO:0000312|EMBL:AAU06141.1};
RA   Li Z.B., Wang X.L.;
RT   "Possible role of TREK-1 in temperature regulation.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAU06141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=19571146; DOI=10.1523/jneurosci.5784-08.2009;
RA   Zhou M., Xu G., Xie M., Zhang X., Schools G.P., Ma L., Kimelberg H.K.,
RA   Chen H.;
RT   "TWIK-1 and TREK-1 are potassium channels contributing significantly to
RT   astrocyte passive conductance in rat hippocampal slices.";
RL   J. Neurosci. 29:8551-8564(2009).
RN   [9]
RP   FUNCTION, TRANSPORTER ACTIVITY, INTERACTION WITH GNG4, REGION, AND
RP   MUTAGENESIS OF GLY-144 (ISOFORM 2).
RX   PubMed=23021213; DOI=10.1016/j.cell.2012.09.005;
RA   Woo D.H., Han K.S., Shim J.W., Yoon B.E., Kim E., Bae J.Y., Oh S.J.,
RA   Hwang E.M., Marmorstein A.D., Bae Y.C., Park J.Y., Lee C.J.;
RT   "TREK-1 and Best1 channels mediate fast and slow glutamate release in
RT   astrocytes upon GPCR activation.";
RL   Cell 151:25-40(2012).
RN   [10]
RP   FUNCTION, TRANSPORTER ACTIVITY, REACTION MECHANISM, ACTIVITY REGULATION,
RP   REGION, AND MUTAGENESIS OF ILE-155; THR-156; THR-157; ILE-158; ASN-162;
RP   ILE-163; THR-265; THR-266 AND ILE-267.
RX   PubMed=26919430; DOI=10.1016/j.cell.2016.02.002;
RA   Schewe M., Nematian-Ardestani E., Sun H., Musinszki M., Cordeiro S.,
RA   Bucci G., de Groot B.L., Tucker S.J., Rapedius M., Baukrowitz T.;
RT   "A Non-canonical Voltage-Sensing Mechanism Controls Gating in K2P K(+)
RT   Channels.";
RL   Cell 164:937-949(2016).
RN   [11]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=31630908; DOI=10.1016/j.neuron.2019.08.042;
RA   Kanda H., Ling J., Tonomura S., Noguchi K., Matalon S., Gu J.G.;
RT   "TREK-1 and TRAAK Are Principal K+ Channels at the Nodes of Ranvier for
RT   Rapid Action Potential Conduction on Mammalian Myelinated Afferent
RT   Nerves.";
RL   Neuron 104:960-971.e7(2019).
CC   -!- FUNCTION: K(+) channel that conducts voltage-dependent outward
CC       rectifying currents upon membrane depolarization. Voltage sensing is
CC       coupled to K(+) electrochemical gradient in an 'ion flux gating' mode
CC       where outward but not inward ion flow opens the gate. Converts to
CC       voltage-independent 'leak' conductance mode upon stimulation by various
CC       stimuli including mechanical membrane stretch, acidic pH, heat and
CC       lipids. Reversibly converts between a voltage-insensitive K(+) 'leak'
CC       channel and a voltage-dependent outward rectifying K(+) channel in a
CC       phosphorylation-dependent manner (PubMed:11319556, PubMed:16248991,
CC       PubMed:19571146, PubMed:24196565, PubMed:26919430). Homo- and
CC       heterodimerizes to form functional channels with distinct regulatory
CC       and gating properties (PubMed:24196565). In trigeminal ganglia sensory
CC       neurons, the heterodimer of KCNK2/TREK-1 and KCNK18/TRESK inhibits
CC       neuronal firing and neurogenic inflammation by stabilizing the resting
CC       membrane potential at K(+) equilibrium potential as well as by
CC       regulating the threshold of action potentials and the spike frequency
CC       (By similarity). At trigeminal A-beta afferent nerves, the heterodimer
CC       of KCNK2/TREK-1 and KCNK4/TRAAK is mostly coexpressed at nodes of
CC       Ranvier where it conducts voltage-independent mechanosensitive and
CC       thermosensitive currents, allowing rapid action potential
CC       repolarization, high speed and high frequence saltatory conduction on
CC       myelinated nerves to ensure prompt sensory responses (PubMed:31630908).
CC       In hippocampal astrocytes, the heterodimer of KCNK2/TREK-1 and
CC       KCNK1/TWIK-1 allows passive K(+) conductance under basal conditions,
CC       but changes ion selectivity and becomes permeable to L-glutamate and
CC       Cl(-) ions upon binding to G-protein subunit GNG4 in stimulated
CC       astrocytes. Mediates rapid L-glutamate release in response to
CC       activation of G-protein-coupled receptors such as F2R and CNR1
CC       (PubMed:23021213). In hippocampal pyramidal neurons, the homodimer of
CC       KCNK2/TREK-1 contributes to gamma-aminobutyric acid (GABA) B-induced
CC       slow inhibitory postsynaptic potential. Associates with AKAP5 and Gs-
CC       protein-coupled receptor B2AR at postsynaptic dense bodies and converts
CC       to a leak channel no longer sensitive to stimulation by arachidonic
CC       acid, acidic pH or mechanical stress, nor inhibited by Gq-coupled
CC       receptors but still under the negative control of Gs-coupled receptors
CC       (By similarity). Permeable to other monovalent cations such as Rb(+)
CC       and Cs(+) (PubMed:26919430). {ECO:0000250|UniProtKB:P97438,
CC       ECO:0000269|PubMed:11319556, ECO:0000269|PubMed:16248991,
CC       ECO:0000269|PubMed:19571146, ECO:0000269|PubMed:23021213,
CC       ECO:0000269|PubMed:24196565, ECO:0000269|PubMed:26919430,
CC       ECO:0000269|PubMed:31630908}.
CC   -!- FUNCTION: [Isoform 5]: Does not display channel activity but reduces
CC       the channel activity of isoform 1, isoform 2 and isoform 4 and reduces
CC       cell surface expression of isoform 2. {ECO:0000269|PubMed:24196565}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:16248991, ECO:0000269|PubMed:19571146,
CC         ECO:0000269|PubMed:24196565, ECO:0000269|PubMed:26919430,
CC         ECO:0000269|PubMed:31630908};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamate(out) = L-glutamate(in); Xref=Rhea:RHEA:66336,
CC         ChEBI:CHEBI:29985; Evidence={ECO:0000269|PubMed:23021213};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:23021213};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Rb(+)(in) = Rb(+)(out); Xref=Rhea:RHEA:78547,
CC         ChEBI:CHEBI:49847; Evidence={ECO:0000269|PubMed:19571146,
CC         ECO:0000269|PubMed:26919430};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cs(+)(in) = Cs(+)(out); Xref=Rhea:RHEA:78555,
CC         ChEBI:CHEBI:49547; Evidence={ECO:0000269|PubMed:19571146,
CC         ECO:0000269|PubMed:26919430};
CC   -!- ACTIVITY REGULATION: Activated by various stimuli including
CC       intracellular acidic pH, mechanical stretch and polyunsaturated fatty
CC       acids such as arachidonic acid. {ECO:0000269|PubMed:16248991,
CC       ECO:0000269|PubMed:26919430}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Forms heterodimers with other 2-
CC       pore domain K(+) channel subunits, such as KCNK1, KCNK4, KCNK10 and
CC       KCNK18 (By similarity). Interacts with AKAP5; the channel is recruited
CC       to postsynaptic microdomains by AKAP5 where it can integrate
CC       neurotransmitter receptor signals. Part of a complex composed of AKAP5
CC       and ADRB2. Upon AKAP5 binding, the channel is no longer sensitive to
CC       intracellular acidification, membrane stretch or arachidonic acid
CC       stimuli (By similarity). Interacts with BVES; the interaction enhances
CC       KCNK2 surface expression and is inhibited by cAMP (By similarity).
CC       Interacts (via N-terminus) with G-protein subunit GNG4 (via C-
CC       terminus); this interaction confers ion selectivity to L-glutamate and
CC       Cl(-) anions (PubMed:23021213). {ECO:0000250|UniProtKB:P97438,
CC       ECO:0000269|PubMed:23021213}.
CC   -!- INTERACTION:
CC       Q920B6; P50150: GNG4; Xeno; NbExp=3; IntAct=EBI-6530063, EBI-6395970;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24196565}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, axon
CC       {ECO:0000269|PubMed:31630908}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P97438}. Postsynaptic density membrane
CC       {ECO:0000250|UniProtKB:P97438}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane, sarcolemma {ECO:0000269|PubMed:16248991};
CC       Multi-pass membrane protein {ECO:0000255}. Note=Localizes at the
CC       Ranvier nodes of myelinated afferent nerves.
CC       {ECO:0000269|PubMed:31630908}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1 {ECO:0000269|PubMed:11319556, ECO:0000269|PubMed:11897838};
CC       Synonyms=TREK-1b {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:16248991}; Synonyms=TREK-1a
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-2; Sequence=VSP_053954;
CC       Name=3 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1c
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-3; Sequence=VSP_053952;
CC       Name=4 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1d
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-4; Sequence=VSP_053953;
CC       Name=5 {ECO:0000269|PubMed:24196565}; Synonyms=TREK-1e
CC       {ECO:0000303|PubMed:24196565};
CC         IsoId=Q920B6-5; Sequence=VSP_053954, VSP_053955, VSP_053956;
CC   -!- TISSUE SPECIFICITY: Expressed in cardiomyocytes (at protein level).
CC       Expressed in various brain regions including the lateral olfactory
CC       tract, piriform cortex of the forebrain, paraventricular and
CC       anteromedial thalamic nuclei, brainstem, caudate putamen, nucleus
CC       accumbens, neocortex and interpeduncular nucleus. Detected in
CC       astrocytes in hippocampus stratum radiatum (PubMed:19571146).
CC       {ECO:0000269|PubMed:11897838, ECO:0000269|PubMed:16248991,
CC       ECO:0000269|PubMed:19571146, ECO:0000269|PubMed:24196565}.
CC   -!- TISSUE SPECIFICITY: [Isoform 5]: Expressed in brain and kidney.
CC       {ECO:0000269|PubMed:24196565}.
CC   -!- DOMAIN: The pore-forming domains 1 and 2 assemble to form a single pore
CC       in which M2 and M4 transmembrane helices line the central cavity and M1
CC       and M3 face the lipid bilayer. The transmembrane helices are bridged by
CC       the selectivity filters 1 and 2 carrying a signature sequence TxTTxGYGD
CC       that coordinate the permeant ions. Up to four ions can simultaneously
CC       occupy the selectivity filter and at least two elementary charges must
CC       translocate across the filter to convert it into the open conformation.
CC       {ECO:0000250|UniProtKB:P57789}.
CC   -!- DOMAIN: [Isoform 5]: The C-terminal region of isoform 5 mediates its
CC       intracellular retention. {ECO:0000269|PubMed:24196565}.
CC   -!- PTM: Phosphorylation at Ser-348 controls the reversible conversion from
CC       a leak channel to a voltage-dependent channel.
CC       {ECO:0000250|UniProtKB:O95069}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF325671; AAL01159.1; -; mRNA.
DR   EMBL; AF385402; AAL95708.1; -; mRNA.
DR   EMBL; AY727922; AAU25945.1; -; mRNA.
DR   EMBL; AY555072; AAT64134.1; -; mRNA.
DR   EMBL; AY555073; AAT64135.1; -; mRNA.
DR   EMBL; DQ403851; ABD64605.1; -; mRNA.
DR   EMBL; AY695826; AAU06141.1; -; mRNA.
DR   EMBL; AABR06076806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06076809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473985; EDL94961.1; -; Genomic_DNA.
DR   EMBL; CH473985; EDL94962.1; -; Genomic_DNA.
DR   RefSeq; NP_742038.2; NM_172041.2.
DR   RefSeq; NP_742039.1; NM_172042.1. [Q920B6-1]
DR   RefSeq; XP_006250495.1; XM_006250433.3. [Q920B6-4]
DR   RefSeq; XP_006250496.1; XM_006250434.3. [Q920B6-2]
DR   AlphaFoldDB; Q920B6; -.
DR   SMR; Q920B6; -.
DR   IntAct; Q920B6; 9.
DR   STRING; 10116.ENSRNOP00000003684; -.
DR   BindingDB; Q920B6; -.
DR   ChEMBL; CHEMBL3817718; -.
DR   GlyCosmos; Q920B6; 2 sites, No reported glycans.
DR   GlyGen; Q920B6; 2 sites.
DR   PhosphoSitePlus; Q920B6; -.
DR   PaxDb; 10116-ENSRNOP00000003684; -.
DR   Ensembl; ENSRNOT00000003684.6; ENSRNOP00000003684.4; ENSRNOG00000002653.8. [Q920B6-1]
DR   Ensembl; ENSRNOT00000077282.2; ENSRNOP00000068842.1; ENSRNOG00000002653.8. [Q920B6-3]
DR   Ensembl; ENSRNOT00000103519.1; ENSRNOP00000077148.1; ENSRNOG00000002653.8. [Q920B6-4]
DR   Ensembl; ENSRNOT00000107139.1; ENSRNOP00000087071.1; ENSRNOG00000002653.8. [Q920B6-2]
DR   Ensembl; ENSRNOT00055018647; ENSRNOP00055015029; ENSRNOG00055010998. [Q920B6-1]
DR   Ensembl; ENSRNOT00060023208; ENSRNOP00060018407; ENSRNOG00060013583. [Q920B6-1]
DR   Ensembl; ENSRNOT00065028133; ENSRNOP00065022248; ENSRNOG00065016832. [Q920B6-1]
DR   GeneID; 170899; -.
DR   KEGG; rno:170899; -.
DR   UCSC; RGD:621448; rat. [Q920B6-1]
DR   AGR; RGD:621448; -.
DR   CTD; 3776; -.
DR   RGD; 621448; Kcnk2.
DR   eggNOG; KOG1418; Eukaryota.
DR   GeneTree; ENSGT00940000156560; -.
DR   HOGENOM; CLU_022504_10_0_1; -.
DR   InParanoid; Q920B6; -.
DR   OMA; MTPCKRT; -.
DR   OrthoDB; 600333at2759; -.
DR   PhylomeDB; Q920B6; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-RNO-1299503; TWIK related potassium channel (TREK).
DR   Reactome; R-RNO-5576886; Phase 4 - resting membrane potential.
DR   PRO; PR:Q920B6; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Proteomes; UP000234681; Chromosome 13.
DR   Bgee; ENSRNOG00000002653; Expressed in frontal cortex and 15 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0097449; C:astrocyte projection; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0044305; C:calyx of Held; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:RGD.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISO:RGD.
DR   GO; GO:0003231; P:cardiac ventricle development; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007613; P:memory; IEP:RGD.
DR   GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IMP:RGD.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:1900039; P:positive regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   Gene3D; 1.10.287.70; -; 1.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003976; 2pore_dom_K_chnl_TREK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003:SF21; POTASSIUM CHANNEL SUBFAMILY K MEMBER 2; 1.
DR   PANTHER; PTHR11003; POTASSIUM CHANNEL, SUBFAMILY K; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01499; TREKCHANNEL.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Neurotransmitter transport; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..426
FT                   /note="Potassium channel subfamily K member 2"
FT                   /id="PRO_0000426718"
FT   TOPO_DOM        1..61
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        62..82
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        144..170
FT                   /note="Pore-forming; Name=Pore-forming 1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        172..192
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        193..222
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        223..243
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        253..283
FT                   /note="Pore-forming; Name=Pore-forming 2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..426
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          17..38
FT                   /note="Important for GNG4 binding and L-glutamate release
FT                   in astrocytes"
FT                   /evidence="ECO:0000269|PubMed:23021213"
FT   REGION          51..61
FT                   /note="Important for GNG4 binding and L-glutamate release
FT                   in astrocytes"
FT                   /evidence="ECO:0000269|PubMed:23021213"
FT   REGION          157..162
FT                   /note="Selectivity filter 1"
FT                   /evidence="ECO:0000305|PubMed:26919430"
FT   REGION          266..271
FT                   /note="Selectivity filter 2"
FT                   /evidence="ECO:0000305|PubMed:26919430"
FT   REGION          313..326
FT                   /note="Interaction with AKAP5"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   REGION          337..385
FT                   /note="Essential for chloroform and halothane sensitivity"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         157
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         157
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         158
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         158
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         159
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         159
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         160
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         266
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         266
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         267
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         267
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         268
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         268
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   BINDING         269
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   SITE            141
FT                   /note="pH sensor"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   MOD_RES         348
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:O95069"
FT   CARBOHYD        110
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        108
FT                   /note="Interchain (with C-108)"
FT                   /evidence="ECO:0000250|UniProtKB:P97438"
FT   VAR_SEQ         1..16
FT                   /note="MLASASRERPGYTAGV -> MMNPRAKRSVYL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053952"
FT   VAR_SEQ         1..15
FT                   /note="MLASASRERPGYTAG -> MGA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053953"
FT   VAR_SEQ         2..16
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16248991,
FT                   ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053954"
FT   VAR_SEQ         213..241
FT                   /note="KWNVSQTKIRIISTIIFILFGCVLFVALP -> VGRTLNIWTSTSSSCGSGS
FT                   SLGWPTLRLF (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053955"
FT   VAR_SEQ         242..426
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:24196565"
FT                   /id="VSP_053956"
FT   MUTAGEN         155
FT                   /note="I->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         156
FT                   /note="T->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         157
FT                   /note="T->C: Loss of voltage-dependent channel gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         158
FT                   /note="I->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         162
FT                   /note="N->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         163
FT                   /note="I->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         265
FT                   /note="T->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         266
FT                   /note="T->C: Loss of voltage-dependent channel gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   MUTAGEN         267
FT                   /note="I->C: No effect on voltage-dependent channel
FT                   gating."
FT                   /evidence="ECO:0000269|PubMed:26919430"
FT   CONFLICT        416
FT                   /note="A -> R (in Ref. 4; ABD64605)"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         Q920B6-2:144
FT                   /note="G->E: Loss of G protein-coupled receptor-induced
FT                   anion conductance in astrocytes."
FT                   /evidence="ECO:0000269|PubMed:23021213"
SQ   SEQUENCE   426 AA;  46912 MW;  CACDA05BBE95FDBC CRC64;
     MLASASRERP GYTAGVAAPD LLDPKSAAQN SKPRLSFSAK PTVLASRVES DSAINVMKWK
     TVSTIFLVVV LYLIIGATVF KALEQPQEIS QRTTIVIQKQ NFIAQHACVN STELDELIQQ
     IVTAINAGII PLGNNSNQVS HWDLGSSFFF AGTVITTIGF GNISPRTEGG KIFCIIYALL
     GIPLFGFLLA GVGDQLGTIF GKGIAKVEDT FIKWNVSQTK IRIISTIIFI LFGCVLFVAL
     PAVIFKHIEG WSALDAIYFV VITLTTIGFG DYVAGGSDIE YLDFYKPVVW FWILVGLAYF
     AAVLSMIGDW LRVISKKTKE EVGEFRAHAA EWTANVTAEF KETRRRLSVE IYDKFQRATS
     VKRKLSAELA GNHNQELTPC RRTLSVNHLT SEREVLPPLL KAESIYLNGL TPHCAAEDIA
     VIENMK
//
